drug

D3S-002

Phase 2updated 3mo ago

by D3 Bio Inc

Phase 2

community read0 votes

indications

NSCLC

all catalysts(0)

nothing on the calendar yet

Trials studying D3S-002

phase2A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutationsrecruitingn=67

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 36m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

D3S-002

Phase 2updated 3mo ago

by D3 Bio Inc

Phase 2

community read0 votes

indications

NSCLC

all catalysts(0)

nothing on the calendar yet

Trials studying D3S-002

phase2A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutationsrecruitingn=67

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 36m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

D3S-002

indications

all catalysts(0)

Trials studying D3S-002

News(0)

Report a data issue

comments(0)

D3S-002

indications

all catalysts(0)

Trials studying D3S-002

News(0)

Report a data issue

comments(0)